SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, Peter Salanki, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

A stronger-than-expected quarterly report, raised outlook and record backlog have revived confidence in CoreWeaves AI-compute demand, while managements emphasis on customer prepayments and contract-backed financing addressed some funding concerns. Traders are broadly bullish and discussing a possible short squeeze, but skeptics remain focused on heavy debt, interest costs, capital spending and the path to sustainable profitability.

Netlist, Inc. engages in the design, manufacture and sale of memory subsystems for the computing and communications markets. Its products include enterprise SSD, embedded flash, memory module, lightning DDR5 DIMM, SK hynix, AI server. The company was founded by Jayesh Bhakta, Chun Ki Hong and Christopher Lopes in June 2000 and is headquartered in Irvine, CA.

Netlist Inc

Netlists Q3 results and earnings call are drawing attention, with traders focused on improved profitability and margins, Samsung licensing revenue, and expected recurring Samsung and Micron payments alongside stronger Q4 operating income. Sentiment is broadly bullish on the financial turnaround and AI-memory growth plans, though some question the reported results versus lofty estimates, lower product sales, and the lack of concrete SK Hynix or Nasdaq updates.

Rigetti Computing, Inc. provides full-stack quantum computing services. It serves global enterprise, government, and research clients through its Rigetti Quantum Cloud Services platform. The company was founded by Chad Rigetti in 2013 and is headquartered in Berkeley, CA.

Rigetti Computing Inc

Rigettis Q3 results missed revenue and adjusted-loss expectations, while its outlook heightened concerns about commercialization and cash burn, driving bearish discussion. Some traders remain focused on technology progress and long-term quantum potential, but others question the companys valuation given its limited revenue.

CRISPR Therapeutics AG is a gene editing company, which engages in the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. Its CRISPR/Cas9 platform is a gene editing technology that allows for precise, directed changes to genomic DNA. The firm offers a portfolio of therapeutic programs across a broad range of disease areas including hemoglobinopathies, oncology, regenerative medicine, and rare diseases. The company was founded by Rodger Novak, Emmanuelle Charpentier, Shaun Patrick Foy, Matthew Porteus, Daniel Anderson, Chad Cowan, and Craig Mellow on October 31, 2013 and is headquartered in Zug, Switzerland.

CRISPR Therapeutics AG

CRSP is drawing attention after a sharp, high-volume selloff, with traders pointing to encouraging CTX310 clinical data and continued Casgevy growth while questioning the stocks weak reaction to those developments. Some view the decline as a flush near support; others see it as another sign that positive updates have not produced sustained gains.

Legend Biotech Corp. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, manufacturing, and commercialization of novel therapies for oncology and other indications. The firm develops advanced cell therapies across a diverse array of technology platforms, including autologous and allogeneic chimeric antigen receptor T-cell, gamma-delta T cell and natural killer cell-based immunotherapy. It operates through the following geographical segments: United States of America, China, and Other. The company was founded in 2014 and is headquartered in Bridgewater, NJ.

Legend Biotech Corp - ADR

Legend Biotech

Legend Biotech shares are under pressure after its results and outlook highlighted slower-than-expected U.S. uptake of CARVYKTI, despite continued overall growth and a return to profitability. Traders debate whether the selloff is an overreaction or reflects softer near-term growth expectations; bullish voices point to international expansion and upcoming in-vivo CAR-T data.

Senseonics Holdings, Inc. is a medical technology company, which engages in the development and manufacture of glucose monitoring products. Its primary product is the brand Eversense CGM (continuous glucose monitoring) including sensors, smart transmitters, and mobile applications. The company was founded on June 26, 2014 and is headquartered in Germantown, MD.

Senseonics Holdings Inc

Senseonics Q3 results, strong year-over-year revenue growth and another increase to full-year guidance drove a sharp rally, followed by a steep fade as traders took profits. The community is split between viewing the commercial progress as a positive shift and worrying that ongoing losses, cash needs and management execution could limit the gains.

RUM Group, Inc. engages in operating an online neutral video platform. It operates through the following geographical segments: United States, Canada, and Other. The company was founded in October 2013 by Chris Pavlovski and is headquartered in Longboat Key, FL.

RUM Group Inc. - Ordinary Shares - Class A

RUM Group Inc.

RUM is drawing attention ahead of its Q3 earnings, with traders focused on whether Northern Data/Quake AI revenue and the reported Anthropic compute agreement can deliver growth. Bulls point to elevated short interest as potential squeeze fuel, while skeptics question the deals revenue visibility and the financing needed to fund expansion.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricors Q3 call reaffirmed that deramiocels application for Duchenne muscular dystrophy is in final FDA review ahead of the November 22 decision, keeping the upcoming regulatory ruling at the center of discussion. Many traders took managements confidence and launch preparations as encouraging, while others stressed that approval is uncertain given the FDA advisory committees earlier concerns and the binary nature of the decision; the share decline also prompted debate over earnings and market trading.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Nvidia is under pressure as traders debate the boards investigation into CEO Jensen Huangs relationship with a woman suspected of having Chinese intelligence ties, with concerns centered on governance, national security and possible links to chip shipments to China. The community is split between viewing the controversy as a buying opportunity and worrying that leadership uncertainty could weigh on the company; earnings are also a near-term focus.

D-Wave Quantum, Inc. engages in the development and delivery of quantum computing systems, software, and services. The firm offers annealing and gate-model quantum computing technologies. It provides professional services that assist customers in identifying and implementing quantum computing applications and selling quantum computer systems to customers. The company was founded by Eric Ladizinsky in 1999 and is headquartered in Palo Alto, CA.

D-Wave Quantum Inc

D-Waves Q3 results are driving the selloff, with traders weighing revenue growth and a larger backlog against weaker recent bookings, ongoing losses, and a lofty valuation. Bulls point to longer-term commercial momentum and cash reserves, while skeptics question whether bookings will convert into meaningful revenue soon.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

CSX director John J. Zillmer sold $999K of $CSX on Oct 26, per Form 4. 
 
CSX&#39;s Quality Score went from 17 to 14 the day the filing came out. 
 
getbreakaway.com/CSX

CSX Quality Score 15 (Excellent), #2 of 6 in Railroads. Expected to report Thu Jan 28, 2027. RSI 14 at 69.8, 7.0% above its 50-day average.

Breakaway

CSX (CSX) stock

StockTwits Web

CSX Corp.

CSX director John J. Zillmer sold $999K of 

 on Oct 26, per Form 4. 
 
CSX's Quality Score went from 17 to 14 the day the filing came out. 
 
